A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

Anavex Life Sciences (AVXL) stock falls as the company faces a potential failure to win EU approval for its Alzheimer’s ...

Anavex Life Sciences ( ($AVXL) ) has issued an update. On November 14, 2025, Anavex Life Sciences announced that the Committee for Medicinal ...

The roadmap to fighting Alzheimer’s disease is a matter of updating government policy to match the current science.

Anavex Life Sciences said European regulators informed it of a negative trend vote related to its application for its blarcamesine treatment of early Alzheimer's disease. The Committee for Medicinal ...

Shares of Anavex Life Sciences (AVXL) slumped 8% in the premarket session on Friday after a European Medicines Agency (EMA) ...

Investing.com -- Anavex Life Sciences Corp. (NASDAQ:AVXL) stock plummeted 50% after the company received a negative trend vote from the European Medicines Agency’s Committee for Medicinal Products for ...

An artificial intelligence tool that can predict a patient’s health has been created by Victorian researchers, introducing a ...

CereCura was co-founded by renowned scientist and UBC professor Pieter Cullis, who developed LNPs, the drug delivery system ...

A Pentagon official says the U.S. military's 20th strike on a boat accused of transporting drugs has killed four people in ...

Anavex stock plunged 50% in premarket trading after European regulators issued a negative vote on its Alzheimer’s drug ...

My personal journey proves confronting Alzheimer’s can transform lives — and that public action is essential. It is a wake-up ...